Inhaled Insulin for the Treatment of Type 2 Diabetes
October 18, 2007 | Evidence Reports
Insulin for preprandial glucose control can be administered through several routes, including, but not limited to, injection and inhalation. The inhaled insulin product on the market in the United States and Europe is the Exubera® system. The system consists of a 10-inch long administration device that is used within 10 minutes before a meal, and the patient can inhale specific insulin doses (e.g., 3 units, 6 units, 8 units, 11 units, or higher).
Inhaled insulin can be used on an inpatient or outpatient basis. Because inhaled insulin is used just before meals, treatment with inhaled insulin could...